Navigation Links
MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection
Date:3/13/2008

Combined data from two Phase 3 trials show clinical success rates

statistically equivalent to oral antibiotic therapy

WELLESLEY HILLS, Mass., March 13 /PRNewswire-FirstCall/ -- MacroChem Corporation (OTC Bulletin Board: MACM) announced today the presentation of a poster entitled "Topical versus Systemic Antimicrobial Therapy for Treating Infected Diabetic Foot Ulcers: A Randomized, Controlled, Double-Blinded, Multicenter Trial of Pexiganan Cream." The poster will be presented at the Diabetic Foot Global Conference 2008 in Los Angeles on March 13 to 15 by Benjamin A. Lipsky, MD, FACP, FIDSA, Professor of Medicine, University of Washington and Director, Primary Care Clinic, VA Puget Sound Health Care System.

The poster presents results of two Phase 3 clinical studies, individually and combined, comparing the efficacy of an investigational topical antimicrobial peptide preparation, pexiganan acetate cream, against systemic therapy with an oral fluoroquinolone antibiotic, ofloxacin, for mildly infected diabetic foot ulcers. The authors conclude, in part, that, "The rates of clinical cure or improvement (the primary outcome of the trial) for topical pexiganan and oral ofloxacin were statistically equivalent for the combined studies."

Dr. Lipsky commented that, "To my knowledge, these combined studies are the largest on treatment of diabetic foot infections ever conducted, the only ones that have compared these two routes of therapy, and the first to demonstrate the efficacy of a topical antimicrobial in treating diabetic foot infection in active-controlled trials. Furthermore, having an effective topical therapy available as an alternative to systemic treatment focuses attention on the wound and, in the case of pexiganan, uses a new antimicrobial, while avoiding adverse systemic effects and the promotion of antibiotic resistance."

"We are very pleased that these newly analyzed data are being presented for the first time a
'/>"/>

SOURCE MacroChem Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
2. Synbiotics Corporation Announces Human Submission for FluDetect(R)
3. Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer
4. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
5. Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer
6. Inclinix Announces New Patent for Expert System Platform
7. Genzyme Announces Presentation of New Positive Data on Carticel(R)
8. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
9. AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
10. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
11. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014  CytRx Corporation (Nasdaq: CYTR ... oncology, today announced that David J. Haen , ... NewsMakers in the Biotech Industry Conference on Friday, September 26 ... will take place at the Millennium Broadway Hotel in ... A live and archived webcast of the presentation will ...
(Date:9/19/2014)... 19, 2014 Reductions in kidney ... years in people with diabetes type 2 ... benefits for the kidneys." Australian researchers have ... 2 diabetes leads to persistent reductions in kidney failure ... The global study has found that, five and a ...
(Date:9/18/2014)... ... announced the addition of the "Global ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... chromosomes using molecular biology to understand the ... It plays a crucial role in the ...
Breaking Medicine Technology:CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 3Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 2Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 3
... TRIANGLE PARK, N.C. , June 2 ... it has received a letter from the U.S. Food ... its respiratory products Serevent® and Advair®.  The letter concludes ... committee meetings regarding the safety profile of long-acting beta2-agonists ...
... June 2 The Georgia Advanced Surgery ... first fully accredited surgical center for performing all ... true outpatient setting – has officially opened. ... highly advanced, minimally invasive surgical techniques that spare ...
Cached Medicine Technology:GSK Announces Revised Product Labels for Serevent® and Advair® 2New Georgia Advanced Surgery Center Provides Women Many Unique Benefits 2
(Date:9/20/2014)... Final Cut Pro X Plugin developers ... Information theme for FCPX filmmakers. , “Fun, cool, and simple ... theme,” says Christina Austin, CEO of Pixel Film Studios. “It ... Information features easy to use controls that give the user ... the background color, color of each circle outline, the position ...
(Date:9/20/2014)... 20, 2014 The children of Branches ... and active play they need. An empty lot at ... Lakeview Campus was transformed into a kid-designed playspace in ... volunteers from Branches (@BranchesFL), ESPN (@TeamESPN), Disney (@CitizenDisney), area ... believes a playground is more than a playground. It’s ...
(Date:9/19/2014)... Kansas City, KS (PRWEB) September 19, 2014 ... City, is responding to families in regions of the Philippines ... volcano. , More than 1,060 families evacuated to the ... tropical storm Fung-Wong brought heavy rain and gusty winds to ... Metro-Manila Friday causing heavy flooding. Some homes filled with more ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Hastings and Hastings, ... years in the industry, announces a record number of visitors ... a wide variety of serious injury cases as well as ... with dog bite related accident cases and others. Having served ... Hastings has stood the test of time when it comes ...
(Date:9/19/2014)... Sept. 19, 2014 (HealthDay News) -- U.S. military troops ... of skin cancer, according to a new study. ... abroad, researchers revealed. In some cases, military personnel developed ... the color, shape or size of their moles since ... be risk factors for skin cancer, the study authors ...
Breaking Medicine News(10 mins):Health News:Today Pixel Film Studios Announced the Release of the Information Theme for Final Cut Pro X 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 3Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 4Health News:Double Threat in Philippines Displaces Thousands of Unbound Families 2Health News:Hastings And Hastings Announces a Record Number of Visitors to Its New Phoenix Personal Injury Website 2Health News:Some U.S. Troops May Face Greater Skin Cancer Risk 2
... blood pressure causes inactivation of nitric oxide, a hormone ... If high blood pressure is left untreated, it does ... spiral out of control. According to the researchers at ... rats and found that nitric oxide, which helps control ...
... men suffering from eating disorders. Men who suffer from ... with the same problems, researchers say.// ,Eating ... which become dangerously thin and brittle. This is linked ... particularly calcium.Low bone mineral density (BMD) can lead to ...
... patients who drink in moderation – between one and ... strokes than either abstainers or heavier drinkers who consume ... researchers. ,Dr Kenneth Mukamal and colleagues at Beth ... alcohol consumption among elderly patients appeared to protect against ...
... is not as accurate as first thought, says research. ,Their ... system worked reasonably well for children whose parents were of ... was "misleading".// ,In fact, children of very tall ... worked out for them, and children of extremely short parents ...
... who suffer from constipation are nearly three times more likely ... Robert Frank, Professor of Biostatistics and Statistics at the University ... Parkinson's was noted almost 2 centuries back from a clinical ... one bowel movement per day. This study is part of ...
... have identified a growth factor that triggers blood ... Dr. Jennifer of Genentech Inc. and colleagues reported ... factor, or EG-VEGF. The finding could lead the ... The endocrine glands produce various hormones such as ...
Cached Medicine News:
... Inverness Medical Professional Diagnostics is a ... extensive IFA and DFA test menu that ... and STDs as well as miscellaneous conjugates ... give you a wide assortment of substrates ...
Anti-Skin Antibody (ASA) Test Kit: Pemphigus and Bullous Pemphigoid...
... Diagnostics is a leading provider of immunofluorescence ... test menu that includes kits for autoimmune ... as miscellaneous conjugates and components. Our Impact ... assortment of substrates and kit sizes to ...
... With advanced glass technologies and designs, ... high magnification views of the posterior ... provide image quality previously unattainable with ... for more detailed and comprehensive views, ...
Medicine Products: